Bosh sahifaGOVX • NASDAQ
add
Geovax Labs Inc
Yopilish kursi
2,23 $
Kunlik diapazon
2,04 $ - 2,26 $
Yillik diapazon
1,09 $ - 11,18 $
Bozor kapitalizatsiyasi
19,82 mln USD
Oʻrtacha hajm
718,15 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,79 mln | — |
Joriy xarajat | 1,24 mln | -24,86% |
Sof foyda | -5,82 mln | 30,84% |
Sof foyda marjasi | -208,48 | — |
Har bir ulushga tushum | — | — |
EBITDA | -5,82 mln | 32,14% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 8,59 mln | -32,27% |
Jami aktivlari | 11,11 mln | -31,41% |
Jami passivlari | 2,61 mln | -63,17% |
Umumiy kapital | 8,50 mln | — |
Tarqatilgan aksiyalar | 9,44 mln | — |
Narxi/balansdagi bahosi | 2,25 | — |
Aktivlardan daromad | -192,49% | — |
Kapitaldan daromad | -461,94% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -5,82 mln | 30,84% |
Operatsiyalardan naqd pul | -9,30 mln | -82,45% |
Sarmoyadan naqd pul | -20,65 ming | -233,54% |
Moliyadan naqd pul | 16,35 mln | — |
Naqd pulning sof oʻzgarishi | 7,03 mln | 237,81% |
Boʻsh pul | -7,18 mln | -234,67% |
Haqida
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
Tashkil etilgan
1988
Sayt
Xodimlar soni
17
